TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Nicklas Granqvist Läkarkonsult AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
53
|
1
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
30
|
1
|
0 |
| EBITDA |
30
|
0
|
0 |
| Total assets |
51
|
6
|
6 |
| Current assets |
51
|
6
|
6 |
| Current liabilities |
21
|
1
|
1 |
| Equity capital |
30
|
5
|
5 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
58.8%
|
83.3%
|
83.3% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
56.6%
|
100% | |
| Return on assets (ROA) |
58.8%
|
16.7%
|
0% |
| Current ratio |
242.9%
|
600%
|
600% |
| Return on equity (ROE) |
100%
|
20.0%
|
0% |
| Change turnover |
52
|
1
|
0 |
| Change turnover % | 5970% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.